Many studies have shown that inflammation has an important effect on the development, progression, and also response to treatment of tumors. Dexmedetomidine is a potent and selective alpha 2 receptor agonist, known to have a sedative, analgesic and immune-controlling effect. The purpose of this study is to investigate the effect of dexmedetomidine during surgery on postoperative inflammatory response and surgical recovery in gastric cancer patients undergoing robot or laparoscopic gastrectomy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
CRP level in blood
Timeframe: Preoperative outpatient 1 day visit
CRP level in blood
Timeframe: Immediately after surgery
CRP level in blood
Timeframe: POD 1 day
CRP level in blood
Timeframe: POD 2 day
CRP level in blood
Timeframe: POD 3 day
CRP level in blood
Timeframe: discharge day (Postoperative day 5)
CRP level in blood
Timeframe: first visit after surgery (POD 1 month)